Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
Clinical trial NCT02795520 · TERMINATED
Trial details
- NCT number
- NCT02795520
- Sponsor
- OncoTherapy Science, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2021-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.